MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ibd/izag085

Медицинская библиотека · Inflammatory bowel diseases · 2026

Chronic opioid use and the risk of infections and death in patients with inflammatory bowel disease: a nationwide cohort study based on real-world data.

Nørgård Bente Mertz, Zeiss Kevin Erichsen, Dalal Rahul S, Lund Ken, Andersen Mette Louise, Kjeldsen Jens, Knudsen Torben, Nielsen Jan

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Chronic opioid use (COU) is frequent in inflammatory bowel disease (IBD), but data on its association with infections and mortality are scarce. We examined (1) hospital-diagnosed infections, (2) prescribed systemic antibiotic/antiviral/antifungal agents, and 3) death associated with COU, and assessed these outcomes according to opioid strength.

METHODS

This nationwide cohort study included all prevalent adult patients with Crohn disease (CD) and ulcerative colitis (UC) in Denmark from January 1, 2000, to June 30, 2023. Chronic opioid use (COU) was a time-varying exposure (≥3 opioid prescriptions within 12 months, with ≥ 30 days between each prescription). Cox regression models were used to estimate adjusted hazard ratios (aHRs), including baseline and time-varying covariates (IBD surgery, IBD medications, and psychotropic medications).

RESULTS

We included 18 897 patients with CD, of whom 3948 (20.9%) had COU. Among those with COU, the aHRs for hospital-diagnosed infections, prescribed antibiotics, and death were 1.91 (95% CI, 1.79-2.04), 1.47 (95% CI, 1.40-1.56), and 1.76 (95% CI, 1.58-1.96), respectively. We included 32 947 patients with UC, of whom 4779 (14.5%) had COU. Among those with COU, the aHRs for hospital-diagnosed infections, prescribed antibiotics, and death were 1.93 (95% CI, 1.80-2.06), 1.56 (95% CI, 1.47-1.65), and 1.74 (95% CI, 1.60-1.90), respectively. Both strong and weak opioids were associated with these adverse outcomes in CD and UC.

CONCLUSIONS

Real-world data have demonstrated an association between COU and increased risks of infections and mortality, independent of opioid strength, affecting users of both strong and weak opioids. Clinicians should be attentive to these risks when prescribing opioids to this population.

Для цитирования: Nørgård Bente Mertz, Zeiss Kevin Erichsen, Dalal Rahul S, Lund Ken, Andersen Mette Louise, Kjeldsen Jens, Knudsen Torben, Nielsen Jan. Chronic opioid use and the risk of infections and death in patients with inflammatory bowel disease: a nationwide cohort study based on real-world data.. Inflammatory bowel diseases. 2026. DOI: 10.1093/ibd/izag085.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.